-
Symbol
-
RAPT on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.0001 par value per share
-
Latest Disclosed Shares Owned
-
13,932,449 shares
-
Security Ownership %
-
9.9%
Shares, Excluding Options vs Price
Value, Excluding Options
Redmile Group, LLC ownership in RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT)
14 Feb 2025 - Redmile Group, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 13,932,449 shares of RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT).
This represents 9.9% ownership of the company.
This is the first filing by Redmile Group, LLC disclosing ownership of RAPT Therapeutics, Inc. Common Stock, $0.0001 par value per share (RAPT).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.